Contractor intelligence · computed from public award records
RAMCO PHARM
- Awards won
- 159
- Known value
- USD 5.5M
- First award
- 11 Nov 2018
- Most recent
- 30 Sept 2024
Wins by funder
| Funder | Awards | Known value | Most recent |
|---|---|---|---|
| World Bank | 159 | USD 5.5M | 30 Sept 2024 |
Where the work is
EG · 159
Sources
The most recent award records behind the figures above. Every number on this page is computed from records like these — nothing is estimated or editorial.
- Purchase of virus C drugs (Ribavirin drugs) · 31 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 27 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 27 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 27 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 27 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 27 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 27 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 26 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 26 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 26 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 26 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 26 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 26 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 26 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 25 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 25 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 25 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 25 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 25 Dec 2018 · USD 2K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 25 Dec 2018 · USD 2K · World Bank
Method
Computed from 159 award records ingested from official disclosure sources (World Bank, Inter-American Development Bank, and published contract-award notices). Values are shown in USD where the source published one; entity identity is resolved conservatively and reviewed. GLODA is not affiliated with any funder or contractor shown. Last computed 15 Sept 2026.